中文 | English
Return
Total: 6 , 1/1
Show Home Prev Next End page: GO
Author:(Yinsheng WEI)

1.Part IV. Synthesis and antitumor evaluation of s-triazolothiadiazines and pyrazolo s-triazoles derived from ciproxacin.

Songqiang XIE ; Yinsheng CHEN ; Guoqiang WANG ; Nannan DUAN ; Xiaoyi WEN ; Tieyao CAO ; Jun YIN ; Wei WANG ; Guoqiang HU ; Wenlong HUANG

Acta Pharmaceutica Sinica 2012;47(1):66-71

2.Investigation on the cognitive level of Mpox among MSM population in Shenzhen and analysis of the influencing factors in 2023

Tianlong XIA ; Shule XU ; Shaochu LIU ; Wei XIE ; Yanpeng CHENG ; Yinsheng GUO ; Jianhua LU ; Yan ZHANG

Chinese Journal of Preventive Medicine 2024;58(5):686-689

3.Investigation on the cognitive level of Mpox among MSM population in Shenzhen and analysis of the influencing factors in 2023

Tianlong XIA ; Shule XU ; Shaochu LIU ; Wei XIE ; Yanpeng CHENG ; Yinsheng GUO ; Jianhua LU ; Yan ZHANG

Chinese Journal of Preventive Medicine 2024;58(5):686-689

4.Pharmacodynamic study of magnesium isoglycyrrhizinate in HBV transgenic mouse model

Hongjiang XU ; Wei SHI ; Wei SONG ; Ying ZHANG ; Kaidi ZHAO ; Yinsheng ZHANG ; Ling YANG ; Jinan WANG

Journal of China Pharmaceutical University 2019;50(4):475-480

5.Advances in the application of duck hepatitis B animal model in pharmaceutical field

Jinan WANG ; Wei SHI ; Wei SONG ; Yaqi ZHANG ; Yinsheng ZHANG ; Hongjiang XU

Journal of China Pharmaceutical University 2018;49(6):746-750

6.Clinical features and prognosis of paraganglioma of the urinary bladder

Zhili YANG ; Liwen LU ; Ting ZHANG ; Wenjian LUO ; Yantong HAN ; Yong ZHANG ; Lingang CUI ; Yinsheng WEI ; Teng LI ; Qingjun MENG

Journal of Modern Urology 2023;28(10):861-866

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 6 , 1/1 Show Home Prev Next End page: GO